Cross study analyses of SEND data: toxicity profile classification
Toxicological Sciences · 01.08.2024 · 200 (2) · 277-286
DOI: 10.1093/toxsci/kfae072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 08.06.2024. Verfasst von Mark A Carfagna und 11 weiteren Autor:innen. Beteiligte Einrichtung: Eli Lilly & Company, Indianapolis, IN 46285, United States. Hauptthemen laut MEDLINE: Toxicity Tests. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
A SEND toxicology data transformation, harmonization, and analysis platform were created to improve the identification of unique findings related to the intended target, species, and duration of dosing using data from multiple studies. The lack of a standardized digital format for data analysis had impeded large-scale analysis of in vivo toxicology studies. The CDISC SEND standard enables the analysis of data from multiple studies performed by different laboratories. This work describes methods to analyze data and automate cross-study analysis of toxicology studies. Cross-study analysis can be used to understand a single compound’s toxicity profile across all studies performed and/or to evaluate on-target versus off-target toxicity for multiple compounds intended for the same pharmacological target. This work involved development of data harmonization/transformation strategies to enable cross-study analysis of both numerical and categorical SEND data. Four de-identified SEND datasets from the BioCelerate database were used for the analyses. Toxicity profiles for key organ systems were developed for liver, kidney, male reproductive tract, endocrine system, and hematopoietic system using SEND domains. A cross-study analysis dashboard with a built-in user-defined scoring system was created for custom analyses, including visualizations to evaluate data at the organ system level and drill down into individual animal data. This data analysis provides the tools for scientists to compare toxicity profiles across multiple studies using SEND. A cross-study analysis of 2 different compounds intended for the same pharmacological target is described and the analyses indicate potential on-target effects to liver, kidney, and hematopoietic systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eli Lilly & Company, Indianapolis, IN 46285, United States.
- US Food & Drug Administration, Silver Spring, MD 20901, United States.
- Oak Ridge Institute for Science and Education, Oak Ridge, TN 37830, United States.
- Shionogi & Co., Ltd, Osaka, 530-8560, Japan.
- Bristol Myers Squibb, New Brunswick, NJ 08901, United States.
- Novo Nordisk, Copenhagen, 2700 Kobenhavn K, Denmark.
ORCID-Profile: Mark A Carfagna, Susan Butler, Tamio Fukushima, William Houser, Nikolai Jensen, Kevin Snyder, Saurabh Vispute, Md Yousuf Ali
Zitieren
APA
Carfagna, M. A., Ahmed, C. S., Butler, S., Fukushima, T., Houser, W., Jensen, N., Paisley, B., Leuenroth-Quinn, S., Snyder, K., Vispute, S., Wang, W., & Ali, M. Y. (2024). Cross study analyses of SEND data: toxicity profile classification. Toxicological Sciences, 200(2), 277-286. https://doi.org/10.1093/toxsci/kfae072
Vancouver
Carfagna MA, Ahmed CS, Butler S, Fukushima T, Houser W, Jensen N, et al. Cross study analyses of SEND data: toxicity profile classification. Toxicological Sciences. 2024;200(2):277-286. doi:10.1093/toxsci/kfae072
BibTeX
@article{Carfagna2024,
author = {Carfagna, Mark A and Ahmed, Cm Sabbir and Butler, Susan and Fukushima, Tamio and Houser, William and Jensen, Nikolai and Paisley, Brianna and Leuenroth-Quinn, Stephanie and Snyder, Kevin and Vispute, Saurabh and Wang, Wenxian and Ali, Md Yousuf},
title = {Cross study analyses of SEND data: toxicity profile classification},
journal = {Toxicological Sciences},
year = {2024},
volume = {200},
number = {2},
pages = {277--286},
doi = {10.1093/toxsci/kfae072}
}
EUVIMED